Evgeny N. Ulomskiy, Daniil N. Lyapustin, Evgeny M. Mukhin, Egor K. Voinkov, Victor V. Fedotov, Konstantin V. Savateev, Oleg S. Eltsov, Evgeny B. Gorbunov, Roman A. Drokin, Vladimir L. Rusinov, Oleg N. Chupakhin, “ANRORC process in 1-alkylazolo[5,1-c][1,2,4]triazin-4(1H)-ones”, Chem Heterocycl Comp, 54, № 1, 2018, 63
Tatyana S. Shestakova, Sergey L. Deev, Igor А. Khalymbadzha, Vladimir L. Rusinov, Alexander S. Paramonov, Alexander S. Arseniev, Zakhar O. Shenkarev, Valery N. Charushin, Oleg N. Chupakhin, “Antiviral drug Triazavirin, selectively labeled with 2H, 13C, and 15N stable isotopes. Synthesis and properties”, Chem Heterocycl Comp, 57, № 4, 2021, 479
Ivanka Stankova, Kiril Chuchkov, Radoslav Chayrov, Luchia Mukova, Angel Galabov, Desislava Marinkova, Dancho Danalev, “Adamantane Derivatives Containing Thiazole Moiety: Synthesis, Antiviral and Antibacterial Activity”, Int J Pept Res Ther, 26, № 4, 2020, 1781
Abolfazl Akbari, Mahya Razmi, Alireza Sedaghat, Seyyed Mohammad Matin Alavi Dana, Mahdi Amiri, Ali Mohammad Halvani, Soroush Yazdani, Sajad Sahab-Negah, “Comparative effectiveness of pharmacological interventions on mortality and the average length of hospital stay of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials”, Expert Review of Anti-infective Therapy, 20, № 4, 2022, 585
T. S. Shestakova, S. L. Deev, O. S. Eltsov, I. A. Khalymbadzha, V. A. Shevyrin, V. L. Rusinov, V. N. Charushin, O. N. Chupakhin, “Analog of antiviral drug Triazavirin (Riamilovir) labeled with stable isotopes 13C and 15N. Synthesis and NMR characteristics”, Russ Chem Bull, 73, № 2, 2024, 372
Olga V. Berdiugina, Evgeniy Yu. Gusev, “Some results of riamilovir (triazavirine) usage in medical staff for prevention and treatment of COVID-19”, Russian Journal of Immunology, 26, № 3, 2023, 223
S.L. Deev, M.V. Yasko, I.L. Karpenko, A.N. Korovina, A.L. Khandazhinskaya, V.L. Andronova, G.A. Galegov, T.S. Shestakova, E.N. Ulomskii, V.L. Rusinov, O.N. Chupakhin, M.K. Kukhanova, “1,2,4-Triazoloazine derivatives as a new type of herpes simplex virus inhibitors”, Bioorganic Chemistry, 38, № 6, 2010, 265
Pengtao Jiao, Wenhui Fan, Ying Cao, He Zhang, Lu Tian, Lei Sun, Tingrong Luo, Wenjun Liu, Jing Li, Kui Li, “Robust induction of interferon and interferon-stimulated gene expression by influenza B/Yamagata lineage virus infection of A549 cells”, PLoS ONE, 15, № 4, 2020, e0231039
V V Egorov, Ya A Zabrodskaya, D V Lebedev, A N Gorshkov, A I Kuklin, “Structural features of the ionic self-complementary amyloidogenic peptide”, J. Phys.: Conf. Ser., 848, 2017, 012022
Malík Ivan, Čižmárik Jozef, Kováč Gustáv, Pecháčová Mária, Hudecová Lucia, “Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)”, CSF, 70, № 1, 2021, 18